Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Estudio de fase 1b que combina dinutuximab beta (DB) con regímenes de quimioterapia de inducción en pacientes con neuroblastoma de alto riesgo de reciente diagnóstico.

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping with an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45)

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

AFFIRM: A Randomized, double-blind, placebo-controlled, study to evaluate the effect of Seladelpar on clinical outcomes in patients with primary biliary cholangitis (PBC) and compensated cirrhosis.

  • Protocol code: CB8025-41837
  • EudraCT code: _
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Villagrasa Vilella, Ares Aurora
  • Research group:  Malalties hepàtiques
  • Service: Hepatologia
  • Phase: Fase III
  • Recruiting: Closed
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Year
2025
Títol Complet
Service provider of a comprehensive tool for genomic analysis and online biological data interpretation of Pediatric Tumors for the Childhood Cancer and Hematologic Diseases Group of the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR)
Expedient
GENOMIC ANALYSIS OF PEDIATRIC TUMORS
Codi
24985454
Data publicació

Professionals

Andrea Casal Pardo

Professionals

Sandra León Cobos

Professionals

Alfredo Pueyo Ferrer

I have been an assistant doctor at the Ophthalmology Department of the Vall d'Hebron Hospital since 2016, where I am dedicated to the medical-surgical pathology of the anterior ocular segment. I am particularly interested in ocular surface and corneal pathology, as well as cataract surgery and intra
Year
2025
Títol Complet
Servicio de firmas electrónicas para la Unidad de Servicios Jurídico de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR).
Expedient
FIRMAS ELECTRÓNICAS VHIR
Codi
24985357
Data publicació

Activities

Doctoral thesis Respiratory complications following SARS-CoV-2 infection

Doctoral candidate: David Espejo CastellanosDirectors: Dr. María Jesús Cruz Carmona and Dr. Xavier Muñoz GallTutor: Dr. Jaume Ferrer Sancho

Activities

Tesis doctoral Asthma due to exposure to allergens and other environmental pollutants: inflammatory and immunologic response

Doctoral candidate: David Soler SegoviaDirectors: Dr. María Jesús Cruz Carmona and Dr. Xavier Muñoz GallTutor: Dra. María Jesús Cruz Carmona
Year
2025
Títol Complet
Serveis d'auditoria externa per evidenciar el nivell de compliment dels requisits del sistema de gestió de la qualitat UNE-EN ISO 9001:2015, i la seva posterior adaptació als requisits de la propera nova versió de la norma ISO 9001, si s'escau, a càrrec de la Coordinació de Qualitat, Processos i Gestió documental de la Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR).
Expedient
SERVEI D’AUDITORIA EXTERNA
Codi
24985335
Data publicació
Year
2025
Títol Complet
Hiring a service of DNA and RNA sequencing and specialized bioinformatic analysis from tumor samples and whole blood in the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR)
Expedient
DNA AND RNA SEQUENCING (PI23/01045)
Codi
24985336
Data publicació

Professionals

Federica Stornelli

Professionals

Claire Diot